Rosacea in Crohn's Disease: Effect of Rifaximin

被引：6

作者：

Weinstock, Leonard B. ^{[1
,2
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO 63130 USA

[2] Gastroenterol LLC, St Louis, MO USA

来源：

JOURNAL OF CLINICAL GASTROENTEROLOGY | 2011年 / 45卷 / 03期

关键词：

INTESTINAL BACTERIAL OVERGROWTH; THERAPY; TRIAL;

D O I：

10.1097/MCG.0b013e3182040eb2

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：295 / 296

页数：3

共 50 条

[21] Rosacea fulminans in a patient with Crohn's disease: A case report and review of the literature
Romiti, R
Jansen, T
Heldwein, W
Plewig, G
ACTA DERMATO-VENEREOLOGICA, 2000, 80 (02) : 127 - 129
[22] Adjunctive Antibiotic Therapy with Rifaximin May Help Reduce Crohn's Disease Activity
Shafran, Ira
Burgunder, Patricia
DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 1079 - 1084
[23] Adjunctive antibiotic therapy with Rifaximin may help reduce Crohn's disease activity
Shafran, I
INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 672 - 672
[24] Adjunctive Antibiotic Therapy with Rifaximin May Help Reduce Crohn’s Disease Activity
Ira Shafran
Patricia Burgunder
Digestive Diseases and Sciences, 2010, 55 : 1079 - 1084
[25] Rifaximin in IBD: Is It Time to Beat Back the Bugs as Induction Therapy in Crohn's Disease?
Isaacs, Kim L.
INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) : 457 - 458
[26] The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease
Lopetuso, Loris R.
Napoli, Marco
Rizzatti, Gianenrico
Gasbarrini, Antonio
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (06) : 543 - 551
[27] Adjunctive antibiotic therapy with rifaximin may help reduce Crohn's disease activity
Shafran, Ira
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S429 - S429
[28] Effect of rifaximin on intestinal bacterial overgrowth in Crohn's disease as assessed by the H2-glucose breath test
Biancone, L
Vernia, P
Agostini, D
Ferrieri, A
Pallone, F
CURRENT MEDICAL RESEARCH AND OPINION, 2000, 16 (01) : 14 - 20
[29] Rifaximin-EIR in mild to moderate active Crohn's disease (GRACE 02 study)
Lukas, M.
Novotny, A.
Bortlik, M.
Leeder, J.
Palazzini, E.
INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 668 - 668
[30] DOES RIFAXIMIN OFFER ANY PROMISE IN CROHN'S DISEASE AND CONCURRENT IRRITABLE BOWEL SYNDROME?
Tocia, Cristina
Dumitru, Irina Magdalena
Alexandrescu, Luana
Marius, Duduta
Dumitru, Eugen
GASTROENTEROLOGY, 2019, 156 (06) : S73 - S74

← 1 2 3 4 5 →